|
Títol:
|
Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts
|
|
Autor/a:
|
Ni, Xiaohua; Zhang, Yonggang; Ribas i Fortuny, Judit; Chowdhury, Wasim H.; Castanares, Mark; Zhang, Zhewei; Laiho, Marikki; DeWeese, Theodore L.; Lupold, Shawn E.
|
|
Notes:
|
Dose-escalated radiation therapy for localized prostate cancer (PCa) has a clear therapeutic benefit; however, escalated doses may also increase injury to noncancerous tissues. Radiosensitizing agents can improve ionizing
radiation (IR) potency, but without targeted delivery, these agents will also sensitize surrounding normal tissues. Here we describe the development of prostate-targeted RNAi agents that selectively sensitized prostate-specific membrane antigen–positive (PSMA-positive) cells to IR. siRNA library screens identified DNA-activated protein kinase, catalytic polypeptide (DNAPK) as an ideal radiosensitization target. DNAPK shRNAs, delivered by PSMA-targeting RNA aptamers, selectively reduced DNAPK in PCa cells, xenografts, and
human prostate tissues. Aptamer-targeted DNAPK shRNAs, combined with IR, dramatically and specifically enhanced PSMA-positive tumor response to IR. These findings support aptamer-shRNA chimeras as selective
sensitizing agents for the improved treatment of high-risk localized PCa. |
|
Matèries:
|
-Tumors
-Radioteràpia
-Pròstata -- Càncer -- Tractament |
|
Drets:
|
(c) American Society for Clinical Investigation, 2011
|
|
Tipus de document:
|
article
publishedVersion |
|
Publicat per:
|
American Society for Clinical Investigation
|
|
Compartir:
|
|
